XML 13 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Unaudited Condensed Consolidated Income Statements - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue        
Total Revenue $ 238,696 $ 231,358 $ 697,887 $ 665,846
Cost of revenue        
Total Cost of revenue [1] 25,164 48,807 80,266 125,890
Gross profit 213,532 182,551 617,621 539,956
Operating expenses:        
Sales and marketing 89,368 81,216 260,421 245,801
Product, technology, and development 36,316 36,359 106,936 108,484
General and administrative 28,463 28,187 82,305 83,682
Impairments 0 7,026 29,633 134,501
Depreciation and amortization 4,711 2,329 13,053 7,354
Total segment expenses 158,858 155,117 492,348 579,822
Income (loss) from operations 54,674 27,434 125,273 (39,866)
Other income, net:        
Interest income 2,292 2,717 7,524 9,063
Other (expense) income, net (399) (94) (271) 122
Total other income, net 1,893 2,623 7,253 9,185
Income (loss) before income taxes 56,567 30,057 132,526 (30,681)
Provision for (benefit from) income taxes 11,850 7,546 26,421 (5,772)
Net income (loss) $ 44,717 $ 22,511 $ 106,105 $ (24,909)
Net income (loss) per share attributable to common stockholders (Note 12)        
Basic $ 0.46 $ 0.22 $ 1.06 $ (0.24)
Diluted $ 0.45 $ 0.21 $ 1.04 $ (0.24)
Weighted-average number of shares of common stock used in computing net income (loss) per share attributable to common stockholders        
Basic 98,170,081 103,321,988 100,033,516 104,769,518
Diluted 99,722,575 105,059,283 101,640,190 104,769,518
Marketplace        
Revenue        
Total Revenue $ 231,653 $ 204,019 $ 665,886 $ 586,405
Cost of revenue        
Total Cost of revenue [1] 16,946 13,521 46,755 41,051
Wholesale        
Revenue        
Total Revenue 2,249 12,107 16,271 41,351
Cost of revenue        
Total Cost of revenue [1],[2] 3,366 20,415 17,883 47,272
Product        
Revenue        
Total Revenue 4,794 15,232 15,730 38,090
Cost of revenue        
Total Cost of revenue [1] $ 4,852 $ 14,871 $ 15,628 $ 37,567
[1] For the three months ended September 30, 2025 and 2024 and for the nine months ended September 30, 2025 and 2024, cost of revenue includes depreciation and amortization expense of $2,645, $2,849, $7,539, and $10,968, respectively.
[2] the three months ended September 30, 2025, there was no impairment recorded in cost of revenue. For the three months ended September 30, 2024 and for the nine months ended September 30, 2025 and 2024, cost of revenue includes impairment of $9,750, $2,919, and $9,930, respectively.